Latest news
Oncologists Discuss Accelerated FDA Approvals and Surrogate Endpoints After Zepzelca Withdrawal - OncodailyOncodaily · Sun, 09 Aug 2026 16:07:14 GMTRecon: Lilly to broaden expanded access for unapproved obesity drug; Jazz to withdraw second-line SCLC indication for Zepzelca - RAPSRAPS · Tue, 04 Aug 2026 20:19:00 GMTJazz to withdraw Zepzelca with FDA in second-line small cell lung cancer - Fierce PharmaFierce Pharma · Tue, 04 Aug 2026 13:18:16 GMT